TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Department of Veteran’s Affairs
Grant: K2BX004346-01A1
Department of Veteran’s Affairs
Grant: R01 DK109384
BLRD VA
Grant: IK2 BX004346
Siteman Cancer Center/Ellis Fischel Cancer Center Foundations
Grant: N/A
National Institutes of Health
Grant: 5R01DK109384-04
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
Siteman Cancer Center/Barnes Jewish Foundation
Siteman Cancer Center/Ellis Fischel Cancer Center Foundations
FWCI
0.16
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals